Vivesto Stock

Vivesto Diluted EPS

The Diluted Earnings per Share of Vivesto (VIVE.ST) as of Aug 16, 2026 is -0.21 SEK. In the previous year, Diluted Earnings per Share was -0.65 SEK — a change of -67.73% (higher).

Diluted EPS

-0.21SEK

YoY

-67.73%

Last updated:

Diluted Earnings per Share of Vivesto is 2026 -0.21 SEK. Diluted Earnings per Share of Vivesto was 2025 -0.65 SEK. It decreases by -67.73% higher compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

Diluted Earnings per Share of Vivesto is -0.21 SEK in 2026.

Diluted Earnings per Share of Vivesto changed from -0.65 SEK to -0.21 SEK, representing a -67.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Vivesto since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

Income Statement — Vivesto

All Key Metrics — Vivesto